olfactory receptor family 10 subfamily D member 4 pseudogeneGenealiases: OR10D4 · OR10D6P
Q-omics provides the consensus-scored OR10D4P profile across patient tissues and cancer cell-line models. OR10D4P expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, OR10D4P is differentially expressed in 2, with the highest sampling consensus in COAD. Additionally, OR10D4P RNA expression shows 7,240 significant protein co-abundance associations, with the highest sampling consensus in PDAC. Together, these results highlight HNSC, COAD, and PDAC as cancer lineages where OR10D4P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR10D4P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR10D4P survival associations across molecular data types. OR10D4P RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR10D4P RNA expression–survival associations across cancer types. High OR10D4P expression shows unfavorable associations in HNSC, SKCM, UVM, LIHC, OV and THCA. The HNSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .005). Together, the overview and detailed table identify HNSC as the clearest survival context for OR10D4P RNA expression.
This table summarizes OR10D4P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for OR10D4P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR10D4P shows lower tumor expression in COAD and LUSC. The COAD box plot shows higher OR10D4P RNA expression in normal versus tumor tissue (log2 FC = −0.013, t-test p = .024).
This table shows molecular features associated with OR10D4P in patient tissues and cancer cell lines. In patient samples, OR10D4P shows the broadest associations at the RNA and protein expression levels, with PDAC recurring as the lineage with the largest associated feature set.
